Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on April 2, 2025
Immunocore to present at upcoming investor conferences
GlobeNewswire
·
April 2, 2025
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England …
Oatly to Report First Quarter 2025 Financial Results on April 30, 2025
GlobeNewswire
·
April 2, 2025
MALMÖ, Sweden, April 02, 2025 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY), the world’s original and largest oat drink company, will report financial results for the first quarter ended March 31, 2025, on Wednesday April 30, 2025 before the U.S. …
VAN RYSEL EXPANDS U.S. DISTRIBUTION CHANNELS FOR ROAD AND GRAVEL OFFERINGS
GlobeNewswire
·
April 2, 2025
San Francisco, CA, April 02, 2025 (GLOBE NEWSWIRE) -- VAN RYSEL, the expert French cycling brand owned by DECATHLON announces its newly expanded U.S. distribution channels including more retail distributors as well as direct-to-consumer and click-and- …
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs
GlobeNewswire
·
April 2, 2025
Financing led by new investor Bain Capital with participation from new investor Wellington Management and all existing investors Proceeds to support advancement of ATSN-201 through potential approval and launch as well as preclinical programs to treat …
Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock
GlobeNewswire
·
April 2, 2025
MONACO, April 02, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE …
Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
GlobeNewswire
·
April 2, 2025
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus …
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …
American Tungsten Corp. Joins The Critical Mineral Institute
GlobeNewswire
·
April 2, 2025
Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has become a member of the Critical Minerals Institute (the “CMI”). The CMI …
Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board
GlobeNewswire
·
April 2, 2025
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board. Comprised of prominent leaders from pharmaceutical and technology sectors, the …
Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City. Marex …
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
GlobeNewswire
·
April 2, 2025
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
GlobeNewswire
·
April 2, 2025
NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …
Global Helium Corp. Announces Sale of Standing Well and Lands in Montana
GlobeNewswire
·
April 2, 2025
CALGARY, Alberta, April 02, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("HECO" or the "Company") (CSE: HECO, OTC: HECOF) is pleased to announce the successful sale of one standing well and one section of associated mineral rights located in the Rudyard …
SANTO TOMAS PROJECT MOVES FORWARD
GlobeNewswire
·
April 2, 2025
VANCOUVER, Canada, April 02, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) Last week in Culiacan, Sinaloa, Craig Dalziel, Oroco's Chairman, and other members of Oroco’s Senior Management Team met with …
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
myGwork’s WorkPride 2025 Returns for Sixth Consecutive Year to Champion Workplace Inclusion Worldwide
GlobeNewswire
·
April 2, 2025
LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- myGwork, the world’s largest LGBTQ+ business platform, has announced the return of WorkPride 2025 – its flagship five-day virtual global conference dedicated to workplace inclusion. Now in its sixth consecutive …
Telenor's Subsidiary KNL Signs Framework Agreement with the Finnish and Swedish Defence Forces
GlobeNewswire
·
April 2, 2025
(Stockholm, 2 April, 2025) Telenor expands into the defence industry: Subsidiary KNL signs a ten-year contract with the Finnish and Swedish Defence Forces through NORDEFCO (Nordic Defence Cooperation) for advanced military communication technology. In a …
Telenors datterselskap KNL signerer rammeavtale med det finske og svenske forsvaret
GlobeNewswire
·
April 2, 2025
(Stockholm, 2. april 2025) Telenor forsterker sin posisjon i forsvarsindustrien: Datterselskapet KNL sikrer seg en tiårig kontrakt med det finske og svenske forsvaret gjennom NORDEFCO (Nordic Defence Cooperation) innen banebrytende militær …